1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | 2023 -- H 5347 |
---|
6 | 6 | | ======== |
---|
7 | 7 | | LC000837 |
---|
8 | 8 | | ======== |
---|
9 | 9 | | S TATE OF RHODE IS LAND |
---|
10 | 10 | | IN GENERAL ASSEMBLY |
---|
11 | 11 | | JANUARY SESSION, A.D. 2023 |
---|
12 | 12 | | ____________ |
---|
13 | 13 | | |
---|
14 | 14 | | A N A C T |
---|
15 | 15 | | RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND |
---|
16 | 16 | | SUBSTANCE ABUSE |
---|
17 | 17 | | Introduced By: Representative Joseph J. Solomon |
---|
18 | 18 | | Date Introduced: February 03, 2023 |
---|
19 | 19 | | Referred To: House Health & Human Services |
---|
20 | 20 | | |
---|
21 | 21 | | |
---|
22 | 22 | | It is enacted by the General Assembly as follows: |
---|
23 | 23 | | SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled "Insurance 1 |
---|
24 | 24 | | Coverage for Mental Illness and Substance Abuse" is hereby amended to read as follows: 2 |
---|
25 | 25 | | 27-38.2-1. Coverage for treatment of mental health and substance use disorders. 3 |
---|
26 | 26 | | (a) A group health plan and an individual or group health insurance plan shall provide 4 |
---|
27 | 27 | | coverage for the treatment of mental health and/or substance use disorders under the same terms 5 |
---|
28 | 28 | | and conditions as that coverage is provided for other illnesses and diseases. 6 |
---|
29 | 29 | | (b) Coverage for the treatment of mental health and/or substance use disorders shall not 7 |
---|
30 | 30 | | impose any annual or lifetime dollar limitation. 8 |
---|
31 | 31 | | (c) Financial requirements and quantitative treatment limitations on coverage for the 9 |
---|
32 | 32 | | treatment of mental health and/or substance use disorders shall be no more restrictive than the 10 |
---|
33 | 33 | | predominant financial requirements applied to substantially all coverage for medical conditions in 11 |
---|
34 | 34 | | each treatment classification. 12 |
---|
35 | 35 | | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of 13 |
---|
36 | 36 | | mental health and/or substance use disorders unless the processes, strategies, evidentiary standards, 14 |
---|
37 | 37 | | or other factors used in applying the non-quantitative treatment limitation, as written and in 15 |
---|
38 | 38 | | operation, are comparable to, and are applied no more stringently than, the processes, strategies, 16 |
---|
39 | 39 | | evidentiary standards, or other factors used in applying the limitation with respect to 17 |
---|
40 | 40 | | medical/surgical benefits in the classification. 18 |
---|
41 | 41 | | |
---|
42 | 42 | | |
---|
43 | 43 | | LC000837 - Page 2 of 3 |
---|
44 | 44 | | (e) The following classifications shall be used to apply the coverage requirements of this 1 |
---|
45 | 45 | | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) 2 |
---|
46 | 46 | | Outpatient, out-of-network; (5) Emergency care; (6) Crisis stabilization medications; and (6)(7) 3 |
---|
47 | 47 | | Prescription drugs. 4 |
---|
48 | 48 | | (f) Medication-assisted treatment or medication-assisted maintenance services of substance 5 |
---|
49 | 49 | | use disorders, opioid overdoses, and chronic addiction, including methadone, all federally approved 6 |
---|
50 | 50 | | medications, buprenorphine, naltrexone, or other clinically appropriate medications, is included 7 |
---|
51 | 51 | | within the appropriate classification based on the site of the service. 8 |
---|
52 | 52 | | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine when 9 |
---|
53 | 53 | | developing coverage for levels of care for substance use disorder treatment. 10 |
---|
54 | 54 | | (h) Patients with substance use disorders shall have access to evidence-based, non-opioid 11 |
---|
55 | 55 | | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and 12 |
---|
56 | 56 | | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2. 13 |
---|
57 | 57 | | (i) Parity of cost-sharing requirements. Regardless of the professional license of the 14 |
---|
58 | 58 | | provider of care, if that care is consistent with the provider’s scope of practice and the health plan’s 15 |
---|
59 | 59 | | credentialing and contracting provisions, cost-sharing for behavioral health counseling visits and 16 |
---|
60 | 60 | | medication maintenance visits shall be consistent with the cost-sharing applied to primary care 17 |
---|
61 | 61 | | office visits. 18 |
---|
62 | 62 | | (j) The coverage required by this section shall include a minimum of ninety (90) days of 19 |
---|
63 | 63 | | residential or inpatient services for mental health and/or substance use disorders for American 20 |
---|
64 | 64 | | Society of Addiction Medicine levels of care 3.1 and 3.3. 21 |
---|
65 | 65 | | SECTION 2. This act shall take effect upon passage. 22 |
---|
66 | 66 | | ======== |
---|
67 | 67 | | LC000837 |
---|
68 | 68 | | ======== |
---|
69 | 69 | | |
---|
70 | 70 | | |
---|
71 | 71 | | LC000837 - Page 3 of 3 |
---|
72 | 72 | | EXPLANATION |
---|
73 | 73 | | BY THE LEGISLATIVE COUNCIL |
---|
74 | 74 | | OF |
---|
75 | 75 | | A N A C T |
---|
76 | 76 | | RELATING TO INSURANCE -- INSURANCE COVERAGE F OR MENTAL ILLNESS AND |
---|
77 | 77 | | SUBSTANCE ABUSE |
---|
78 | 78 | | *** |
---|
79 | 79 | | This act would require insurance coverage for a minimum of ninety (90) days of residential 1 |
---|
80 | 80 | | or inpatient services for mental health and/or substance use disorders for American Society of 2 |
---|
81 | 81 | | Addiction Medicine levels of care 3.1 and 3.3. 3 |
---|
82 | 82 | | This act would take effect upon passage. 4 |
---|
83 | 83 | | ======== |
---|
84 | 84 | | LC000837 |
---|
85 | 85 | | ======== |
---|